Cardiac Disease Clinical Trial
— CARDIO-MBSROfficial title:
Impact of Mindfulness-Based Stress Reduction Meditation Practice on Medium- and Long-term Follow-up of Cardiac Patients After Cardiac Rehabilitation.
Verified date | May 2024 |
Source | Elsan |
Contact | Bernard Truong, MD |
Phone | +33622079508 |
cardiotmkb[@]me.com | |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Cardiac rehabilitation is a major component of treatment for patients suffering from coronary pathology revealed by myocardial infarction or acute coronary syndrome warranting transluminal coronary angioplasty, as well as in the aftermath of cardiac surgery. A significant proportion of patients in this situation (40%) suffer from varying degrees of anxiety and depression, which are difficult to treat. These impair their quality of life and can make it more difficult for them to take part in the rehabilitation program, compromising the results that can be expected. Finally, they are often associated with lax compliance with medical treatment, less control of risk factors and less regular exercise. Cardiac rehabilitation teams are well aware of this anxiety-depressive picture, and various therapies such as sophrology, relaxation and yoga have been proposed as alternatives to conventional medical treatments to help patients through this period. Among these alternatives is the concept of "Mindfulness-Based Meditation", based on the Mindfulness-Based Stress Reduction (MBSR) protocol described by Dr. JKabat Zinn. It has been the subject of several prospective randomized studies, which have demonstrated that it is suitable for the management of patients in this situation, and that it has measurable beneficial effects on their sense of well-being. To our knowledge, the MBSR program used in cardiac rehabilitation has never been the subject of a randomized comparative study in France to assess its effectiveness on medium- and long-term anxiety-depressive disorders. This is the objective of this study.
Status | Not yet recruiting |
Enrollment | 74 |
Est. completion date | September 1, 2026 |
Est. primary completion date | September 1, 2026 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: 1. Cardiac patients eligible for cardiac rehabilitation, 2. Patient with a Hospital Anxiety and Depression Scale (HADS) score for the anxiety dimension (HADS-A) >7 or a score for the depression dimension (HADS-D) > 7 3. Age = 18 years 4. Affiliated with a social security scheme or beneficiary of such a scheme 5. Patient signed free and informed consent form Exclusion Criteria: 1. Patients already treated for severe psychiatric disorders (major depression, psychosis, schizophrenia) 2. Inability to follow the 8-week MBSR program 3. Protected patient: minor, adult under guardianship, curatorship or other legal protection, deprived of liberty by judicial or administrative decision 4. Medical conditions which may interfere with the conduct of the study and the investigator's judgment, and which may render the patient unfit to participate in the study. 5. Pregnant or breast-feeding patient 6. Refusal to participate in the study or inability to comply with the study protocol for any reason whatsoever |
Country | Name | City | State |
---|---|---|---|
France | Clinique d'Aressy | Aressy |
Lead Sponsor | Collaborator |
---|---|
Elsan |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline of HADS anxiety and depression scores | HADS (Hospital Anxiety and Depression Scale) is a self questionnaire including 14 items which identifies and quantifies the depression and anxiety from which a person suffers. | Baseline and 12 months | |
Secondary | To assess the quality of life | The patients' quality of life will be measured by the MQOL-R questionnaire, which is a 14-point tool forming 4 subscales: physical, psychological, existential and social. | Baseline, 1 month, 6 months and 12 months | |
Secondary | Medical treatment compliance | The patients' compliance to their medical treatment will be measured by the GIRERD self-questionnaire including 6 questions, to assess compliance, i.e. whether treatment is taken regularly and as prescribed. | Baseline, 1 month, 6 months and 12 months | |
Secondary | Changes from baseline of cardiac risk factor "fasting blood glucose" | fasting blood glucose (in g/L) | Baseline, 1 month, 6 months and 12 months | |
Secondary | Changes from baseline of cardiac risk factor "glycosylated hemoglobin" | glycosylated hemoglobin (% of total hemoglobin) | Baseline, 1 month, 6 months and 12 months | |
Secondary | Changes from baseline of cardiac risk factor "Lipid profile LDLc" | Low Density Lipoprotein cholesterol (g/l)
Tobacco consumption (in packs.year) BMI Ricci Gagnon scale and 6-minute walk test |
Baseline, 1 month, 6 months and 12 months | |
Secondary | Changes from baseline of cardiac risk factor "Lipid profile HDLc" | High Density Lipoprotein cholesterol (g/l) | Baseline, 1 month, 6 months and 12 months | |
Secondary | Changes from baseline of cardiac risk factor "BMI" | BMI ( weight and height will be combined to report BMI in kg/m2) | Baseline, 1 month, 6 months and 12 months | |
Secondary | Changes from baseline of cardiac risk factor "effort" | 6-minute walk test | Baseline, 1 month, 6 months and 12 months | |
Secondary | Changes from baseline of cardiac risk factor "activity" | Ricci Gagnon scale: self questionnaire including 9 questions to evaluate if the subject has an inactive, active or very active profile | Baseline, 1 month, 6 months and 12 months | |
Secondary | Changes from baseline of cardiac risk factor "Tobacco consumption" | Tobacco consumption (in packs.year) | Baseline, 1 month, 6 months and 12 months | |
Secondary | Changes from baseline of cardiac risk factor "Blood pressure measurement" | Blood pressure | Baseline, 1 month, 6 months and 12 months | |
Secondary | To assess the patient's anxiety | HADS anxiety score | Baseline, 1 months and 6 months | |
Secondary | To assess the patient's depression | HADS depression score | Baseline, 1 months and 6 months | |
Secondary | To evaluate the continuation of formal and informal mindfulness meditation practices in patients who have benefited from the MBSR program. | Patients of the MBSR group will be asked two questions :
"Do you still do formal meditation practices?" "Do you still do informal meditation practices?" |
3 months, 6 months and 12 months | |
Secondary | To evaluate the patient's "mindfulness" and its impact on vital aspects in patients who have benefited from the MBSR program. | FFMQ (Five Facets Mindfulness Questionnaire) questionnaire, which includes 39 questions, which assess the 5 facets which constitute mindfulness as a construct:
Describe the experience: talk about the experience in words. Acting mindfully: performing actions with active attention to each step. Non-judgment: absence of positive or negative comments on the thoughts and emotions experienced. Non-reactivity to private events: allowing thoughts and emotions to exist without responding to them automatically. Observation: remaining aware and focused on the experience, even when it is aversive or painful. |
3 months, 6 months and 12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05490303 -
HeartGuide: Preliminary Study
|
N/A | |
Completed |
NCT05070819 -
Atrial Natriuretic Peptide in Assessing Fluid Status
|
N/A | |
Not yet recruiting |
NCT04538469 -
Absent Visitors: The Wider Implications of COVID-19 on Non-COVID Cardiothoracic ICU Patients, Relatives and Staff
|
||
Not yet recruiting |
NCT04511403 -
Prevalence of Oral Mucosal Alterations In a Sample of Egyptian Patients With Cardiovascular Diseases: A Hospital- Based Cross-Sectional Study
|
||
Completed |
NCT02697760 -
The CZT Dynamic Myocardial Perfusion Imaging
|
||
Terminated |
NCT05157568 -
Pilot Randomized Clinical Trial of Live-streamed Cardiovascular Rehabilitation
|
N/A | |
Not yet recruiting |
NCT04160845 -
Non-invasive Forehead Skin Temperature in Cardiac Surgery
|
||
Completed |
NCT04500912 -
Comparison of the Supraflex Cruz 60 Micron Versus the Ultimaster Tansei 80 Micron in HBR PCI Population
|
N/A | |
Recruiting |
NCT06154473 -
Assessment of Patients Undergoing Cardiac Surgery and Admitted to the Intensive Care Unit
|
||
Not yet recruiting |
NCT05877755 -
Validation of Multi-contrast, High-resolution Cardiac Magnetic Resonance Imaging
|
N/A | |
Completed |
NCT03394859 -
Electronic Medical Records and Genomics (eMERGE) Phase III
|
||
Recruiting |
NCT05055830 -
Opportunistic PK/PD Trial in Critically Ill Children (OPTIC)
|
||
Recruiting |
NCT04374799 -
Heparin vs Placebo for Cardiac Catheterization
|
Phase 3 | |
Completed |
NCT03174106 -
Longterm Follow-up of Cardiac Patients With an Smartphone-Application
|
N/A | |
Recruiting |
NCT05531253 -
Respired Gases in Patients Post Cardiac Surgery
|
||
Recruiting |
NCT04609228 -
Cardiac Surgery Outcomes in Blood-transfusion Acceptors and no Acceptors
|
||
Recruiting |
NCT06149143 -
Cardiac Performance System Data Collection Study - Minnesota
|
||
Recruiting |
NCT05725655 -
Hot Water Immersion After Myocardial Infarction
|
N/A | |
Recruiting |
NCT06073509 -
Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT
|
||
Enrolling by invitation |
NCT04886934 -
Temporary Epicardial Pace Wire With Integrated Sensor for Continuous Postoperative Monitoring of Myocardial Function
|
N/A |